Towards quantitative point-of-care testing with novel bioluminescent immunosensor

A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has been developed. Their innovative design leverages BRET -- bioluminescence resonance energy transfer -- and exhibits great potential for point-of-care testing, therapeutic drug monitoring, and environmental applications using paper-based devices.